CDIO Stock Analysis: Buy, Sell, or Hold?
CDIO - Cardio Diagnostics Holdings Inc. Common stock
$1.51
-0.09 (-5.63%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When CDIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CDIO is down 22.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CDIO is down 22.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CDIO is currently trading at $1.51, which is considered oversold relative to its 30-day fair value range of $1.68 to $2.88.
Technical Outlook: Technically, CDIO is in a strong downtrend. The price is currently testing key support at $1.48. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $60.00 (+3873.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CDIO is in a strong downtrend. The price is currently testing key support at $1.48. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $60.00 (+3873.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.68 -
$2.88
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding CDIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 3873.5% below Wall St target ($60.00)
- WARNING: Recommendation downgraded due to -22.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.68 -
$2.88
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.48
Resistance Level
$2.03
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$60.00
(+3873.5%)
Revenue Growth (YoY)
-56.6%
Last updated: February 01, 2026 9:46 AM ET
Data refreshes hourly during market hours. Next update: 10:46 AM
Data refreshes hourly during market hours. Next update: 10:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
Advanced CDIO Option Strategies
Professional options setups generated by AI based on today's CDIO price and gamma walls.